R&D | December 29, 2025
Akums and Sharda University ink MoU to bridge industry–academia gap
The primary goal of the collaboration is joint research into trending and next-generation molecules
The primary goal of the collaboration is joint research into trending and next-generation molecules
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Subscribe To Our Newsletter & Stay Updated
